utidelone
Showing 1 - 7 of 7
Breast Cancer, Neoadjuvant Therapy Trial in Beijing (Utidelone, Carboplatin, Epirubicin)
Not yet recruiting
- Breast Cancer
- Neoadjuvant Therapy
- Utidelone
- +4 more
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Aug 1, 2023
TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)
Recruiting
- TNBC - Triple-Negative Breast Cancer
- Utidelone
- +2 more
-
Wuhan, Hubei, ChinaTongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 5, 2023
Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)
Recruiting
- Breast Cancer
- utidelone
- Bevacizumab
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Sep 15, 2022
Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial (utidelone)
Not yet recruiting
- Breast Neoplasms
- Locally Advanced or Metastatic Breast Cancer
- utidelone
- (no location specified)
May 30, 2022
Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (utidelone, docetaxel)
Not yet recruiting
- Breast Neoplasms
- Locally Advanced or Metastatic Breast Cancer
- utidelone
- docetaxel
-
Guangzhou, Gangdong, ChinaShusen Wang
Jun 21, 2022
SCLC, Extensive Stage Trial in Zhengzhou (Utidelone, Placebo)
Recruiting
- SCLC, Extensive Stage
- Utidelone
- Placebo
-
Zhengzhou, Henan, ChinaHenan Tumor Hospital
Mar 24, 2022
Advanced and Metastatic Breast Cancer Trial in Changsha (Utidelone Injection; capecitabine, Utidelone)
Recruiting
- Advanced and Metastatic Breast Cancer
- Utidelone Injection; capecitabine
- Utidelone
-
Changsha, Hunan, China
- +1 more
Sep 12, 2021